<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Systemic Hypertension</journal-id><journal-title-group><journal-title xml:lang="en">Systemic Hypertension</journal-title><trans-title-group xml:lang="ru"><trans-title>Системные гипертензии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-082X</issn><issn publication-format="electronic">2542-2189</issn><publisher><publisher-name xml:lang="en">Intermedservice Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">29150</article-id><article-id pub-id-type="doi">10.26442/SG29150</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Ethnogenetic aspects of obesity and disorders of carbohydrate metabolism as a risk factor of arterial hypertension</article-title><trans-title-group xml:lang="ru"><trans-title>Этногенетические аспекты ожирения и нарушений углеводного обмена как факторов риска артериальной гипертензии</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Mulerova</surname><given-names>T A</given-names></name><name xml:lang="ru"><surname>Мулерова</surname><given-names>Т А</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, ст. науч. сотр. лаб. эпидемиологии сердечно-сосудистых заболеваний ФГБНУ НИИ КПССЗ, ассистент каф. кардиологии ГБОУ ДПО НГИУВ</p></bio><email>mulerova-77@mail.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tsygankova</surname><given-names>D P</given-names></name><name xml:lang="ru"><surname>Цыганкова</surname><given-names>Д П</given-names></name></name-alternatives><bio xml:lang="ru"><p>мл. науч. сотр. лаб. эпидемиологии сердечно-сосудистых заболеваний ФГБНУ НИИ КПССЗ</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Voropaeva</surname><given-names>E N</given-names></name><name xml:lang="ru"><surname>Воропаева</surname><given-names>Е Н</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, ст. науч. сотр. лаб. молекулярно-генетических исследований терапевтических заболеваний ФГБНУ НИИ ТПМ</p></bio><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Maksimov</surname><given-names>V N</given-names></name><name xml:lang="ru"><surname>Максимов</surname><given-names>В Н</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, зав. лаб. молекулярно-генетических исследований терапевтических заболеваний ФГБНУ НИИ ТПМ</p></bio><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ogarkov</surname><given-names>M Yu</given-names></name><name xml:lang="ru"><surname>Огарков</surname><given-names>М Ю</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, проф., зав. каф. кардиологии ГБОУ ДПО НГИУВ, зав. лаб. эпидемиологии сердечно-сосудистых заболеваний ФГБУ НИИ КПССЗ</p></bio><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Research Institute for Complex Issues of Cardiovascular Diseases</institution></aff><aff><institution xml:lang="ru">ФГБНУ НИИ комплексных проблем сердечно-сосудистых заболеваний</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Novokuznetsk State Institute of Postgraduate Medicine of the Ministry of Health of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ГБОУ ДПО Новокузнецкий государственный институт усовершенствования врачей Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Institution of Internal and Preventive Medicine</institution></aff><aff><institution xml:lang="ru">ФГБНУ НИИ терапии и профилактической медицины</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2016-09-15" publication-format="electronic"><day>15</day><month>09</month><year>2016</year></pub-date><volume>13</volume><issue>3</issue><issue-title xml:lang="en">VOL 13, NO3 (2016)</issue-title><issue-title xml:lang="ru">ТОМ 13, №3 (2016)</issue-title><fpage>48</fpage><lpage>57</lpage><history><date date-type="received" iso-8601-date="2020-04-09"><day>09</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2016, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2016, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/2075-082X/article/view/29150">https://journals.eco-vector.com/2075-082X/article/view/29150</self-uri><abstract xml:lang="en"><p>Objective - to explore the association of candidate genes of arterial hypertension ACE, ADRA2B, ADRB1, MTHFR and eNOS with obesity and impaired glucose metabolism based on ethnicity. Materials and methods. Clinical and epidemiological study of compactly living population in the remote areas of the Mountain Shoria (Orton, Ust-Kabyrza, Sheregesh settlements, Kemerovo region). 1178 residents of these settlements were surveyed with the help of continuous sampling method; the sample consisted of adults (18 years and older). Results. In the group of respondents of the indigenous nationality averages Quetelet index, waist circumference and fasting blood glucose, depending on the polymorphism of candidate genes of arterial hypertension ACE, ADRA2B, ADRB1, MTHFR and eNOS were lower than in non-indigenous ethnic group surveyed. In a population of Shor was found a statistically significant relationship with the body mass index of ACE gene genotypes in a population of non-indigenous representatives - with genotypes of ADRA2B gene. In the group of indigenous ethnic group revealed the relationship from ACE gene polymorphism. Regardless of nationality, found associative connection of the indicator polymorphism of ADRA2B gene. The level of plasma glucose levels in a population of non-indigenous ethnic group was correlated with genotypes of ADRA2B gene. Conclusion. Metabolic abnormalities were detected less frequently in indigenous ethnic group compared with the non-indigenous. In Shor group ACE DD genotype and ADRA2B genes associated with obesity, the genotype 4a/4a eNOS gene - with abdominal obesity. In the group of non-indigenous ethnic group CC genotype of the MTHFR gene was associated with abdominal obesity, II genotype of ACE gene and DD ADRA2B gene - with impaired carbohydrate metabolism.</p></abstract><trans-abstract xml:lang="ru"><p>Цель - изучить ассоциации генов-кандидатов артериальной гипертензии (АГ): ACE, ADRA2B, ADRB1, MTHFR и eNOS - с ожирением и нарушениями углеводного обмена с учетом этнической принадлежности. Материал и методы. Проведено клинико-эпидемиологическое исследование компактно проживающего населения в труднодоступных районах Горной Шории (п. Ортон, п. Усть-Кабырза, п. Шерегеш Кемеровской области). Сплошным методом обследованы 1178 жителей указанных поселков, выборка состояла из взрослого населения (18 лет и старше). Результаты. В группе респондентов коренной национальности средние величины индекса Кетле, окружности талии и глюкозы крови натощак в зависимости от полиморфизма генов-кандидатов АГ - ACE, ADRA2B, ADRB1, MTHFR и eNOS - оказались ниже, чем в группе обследованных некоренного этноса. В популяции шорцев была выявлена статистически значимая взаимосвязь индекса Кетле с генотипами гена AСЕ, в популяции некоренных представителей - с генотипами гена ADRA2B. В группе коренного этноса выявлена взаимосвязь окружности талии с полиморфизмом гена АСЕ. Независимо от национальной принадлежности выявлена ассоциативная связь данного показателя с полиморфизмом гена ADRA2B. Уровень глюкозы плазмы в популяции некоренного этноса был взаимосвязан с генотипами гена ADRA2B. Заключение. Метаболические нарушения были выявлены реже в коренной этнической группе по сравнению с представителями некоренной национальности. В группе шорцев генотипы DD генов АСЕ и ADRA2B ассоциировались с ожирением, генотип 4а/4а гена eNOS - с абдоминальным ожирением. В группе некоренного этноса генотип СС гена MTHFR ассоциировался с абдоминальным ожирением, генотипы II гена АСЕ и DD гена ADRA2B - с нарушениями углеводного обмена.</p></trans-abstract><kwd-group xml:lang="en"><kwd>ethnicity</kwd><kwd>risk factors</kwd><kwd>candidate genes</kwd><kwd>association</kwd><kwd>I/D polymorphism</kwd><kwd>endothelial synthase gene</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>этнос</kwd><kwd>факторы риска</kwd><kwd>гены-кандидаты</kwd><kwd>ассоциации</kwd><kwd>I/D-полиморфизм</kwd><kwd>ген эндотелиальной синтетазы</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Богданов А.Р., Дербенева С.А., Залетова Т.С. Показатели метаболизма и маркеры сердечно - сосудистого риска у больных с различной степенью ожирения. Доктор. Ру. 2013; 2 (80): 31-8.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Бурков Г., Ивлева А.Я. Избыточный вес и ожирение - проблема медицинская, а не косметическая. Ожирение и метаболизм. 2010; 3: 15-9.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Бабин А.Г., Чечеткина Е.А., Колтунов И.Е. Психосоматический аспект ожирения как фактор риска метаболического синдрома. Кардиоваскулярная терапия и профилактика. 2010; 7 (9): 71-8.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Чумакова Г.А., Веселовская Н.Г., Козаренко А.А. Особенности морфологии, структуры и функции сердца при ожирении. Рос. кардиологический журн. 2012; 4: 93-9.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Асташкин Е.И., Глезер М.Г. Ожирение и артериальная гипертония. Проблемы женского здоровья. 2008; 3 (4): 23-33.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Василькова Т.Н., Матаев С.И., Баклаева Т.Б. Влияние различных типов жироотложения на состояние сердечно - сосудистой системы. Сердце: журнал для практикующих врачей. 2014; 1 (13): 45-9.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Cornier M.A, Després J.P, Davis N et al. Assessing adiposity: a scientific statement from the American Heart Association. Circulation 2011; 124 (18): 1996-2019.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Guoheng X. Role of perilipin phosphorylation on the control of lipolysis in adipocytes. Chin J Pathophysiol 2006; 22 (13): 69.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Kado D.M, Huang M.H, Barrett-Connor E, Greendale G.A. Hyperkyphotic posture and poor physical functional ability in older community - dwelling men and women: the rancho bernardo study. J Gerontol A Biol Sci Med Sci 2005; 60 (5): 633-7.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Tuomilehto J, Borch-Johnsen K, Pyorala K. European Diabetes Epidemiology Group. Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study. Diabetologia 2004; 47 (12): 2118-28.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Горбунова В.Н. Генетика и эпигенетика синтропных заболеваний. Экологическая генетика. 2010; 8 (4): 39-43.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Binder A. Identification of genes for a complex trait: examples from hypertension. Curr Pharm Biotechnol 2006; 7 (1): 1-13.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Cоwlеy А.W. Thе gеnеtic dissеctiоn оf еssеntiаl hyреrtеnsiоn. Nаturе Rеv Gеnеtics 2006; 7 (11): 829-40.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Еichlеr Е.Е. Missing hеritаbility аnd strаtеgiеs fоr finding thе undеrlying cаusеs оf cоmрlех disеаsе. Nаt Rеv Gеnеt 2010; 11 (6): 446-50.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Snapir A, Scheinin M, Groop L.C, Orho-Melander M. The insertion/deletion variation in the 2B-adrenoceptor does not seem to modify the risk for acute myocardial infarction, but may modify the risk for hypertension in sib - pairs from families with type 2 diabetes. Cardiovasc Diabetol 2003; 2: 15.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Lima J.J, Feng H, Duckworth L et al. Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations. Metabolism 2007; 56 (6): 757-65.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Salimi S, Firoozrai M, Nourmohammadi I et al. Endothelial nitric oxide synthase gene intron4 VNTR polymorphism in patients with coronary artery disease in Iran. Indian J Med Res 2006; 124 (6): 683-8.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Scott H.A, Gibson P.G, Garg M.L, Wood L.G. Airway inflammation is augmented by obesity and fatty acids in asthma. Eur Respir J 2011; 38(3): 594-602.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>de Koning L, Merchant A.T, Pogue J, Anand S.S. Waist circumference and waist - to - hip ratio as predictors of cardiovascular events: meta - regression analysis of prospective studies. Eur Heart J 2007; 28 (7): 850-6.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Константинов В.В., Деев А.Д., Капустина А.А. Распространенность избыточной массы тела и ее связь со смертностью от сердечно - сосудистых и других хронических неинфекционных заболеваний среди мужского населения в городах разных регионов. Кардиология. 2002; 10: 45-9.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Uemura K, Nakura J, Kohara K, Miki T. Association of ACE I/D polymorphism with cardiovascular risk factors. Hum Genet 2000; 107 (3): 239-42.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Mittal G, Gupta V, Haque S.F, Khan A.S. Effect of angiotensin converting enzyme gene I/D polymorphism in patients with metabolic syndrome in North Indian population. Chin Med J (Engl) 2011; 124 (1): 45-8.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Shunmugam V, Say Y.H. Evaluation of Association of ADRA2A rs553668 and ACE I/D Gene Polymorphisms with Obesity Traits in the Setapak Population, Malaysia. Iran Red Crescent Med J 2016; 18 (2): e22452.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Mao S, Huang S. A meta - analysis of the association between angiotensin - converting enzyme insertion/deletion gene polymorphism and the risk of overweight/obesity. J Renin Angiotensin Aldosterone Syst 2015; 16 (3): 687-94.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Pacholczyk M, Ferenc T, Kowalski J et al. Association of angiotensin - converting enzyme and angiotensin II type I receptor gene polymorphisms with extreme obesity in Polish individuals. DNA Cell Biol 2013; 32 (8): 435-42.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Das M, Pal S, Ghosh A. Synergistic effects of ACE (I/D) and Apo E (Hha I) gene polymorphisms on obesity, fat mass, and blood glucose level among the adult Asian Indians: A population - based study from Calcutta, India. Indian J Endocrinol Metab 2013; 17 (1): 101-4.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Kim K. Association of angiotensin - converting enzyme insertion/deletion polymorphism with obesity, cardiovascular risk factors and exercise - mediated changes in Korean women. Eur J Appl Physiol 2009; 105 (6): 879-87.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Suchánek P, Hubácek J.A, Králová Lesná I et al. Actigenetic of ACE gene polymorphism in Czech obese sedentary females. Physiol Res 2009; 58 (Suppl. 1): S47-52.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Suzuki N, Matsunaga T, Nagasumi K et al. Alpha(2B)-adrenergic receptor deletion polymorphism associates with autonomic nervous system activity in young healthy Japanese. J Clin Endocrinol Metab 2003; 88 (3): 1184-7.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Fava C, Montagnana M, Guerriero M et al. Chromosome 2q12, the ADRA2B I/D polymorphism and metabolic syndrome. J Hypertens 2009; 27 (9): 1794-803.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Etzel J.P, Rana B.K, Wen G et al. Genetic variation at the human alpha2B-adrenergic receptor locus: role in blood pressure variation and yohimbine response. Hypertension 2005; 45 (6): 1207-13.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Laukkanen J.A, Mäkikallio T.H, Kauhanen J, Kurl S. Insertion/deletion polymorphism in alpha2-adrenergic receptor gene is a genetic risk factor for sudden cardiac death. Am Heart J 2009; 158 (4): 615-21.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Zhang H, Li X, Huang J et al. Cardiovascular and metabolic phenotypes in relation to the ADRA2B insertion/deletion polymorphism in a Chinese population. J Hypertens 2005; 23 (12): 2201-7.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Papanas N, Papatheodorou K, Papazoglou D et al. An insertion/deletion polymorphism in the alpha2B adrenoceptor gene is associated with peripheral neuropathy in patients with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2007; 115 (5): 327-30.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Sykiotis G.P, Polyzogopoulou E, Georgopoulos N.A et al. The alpha2B adrenergic receptor deletion/insertion polymorphism in morbid obesity. Clin Auton Res 2003; 13 (3): 203-7.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Vasudevan R, Ismail P, Stanslas J et al. Association of insertion/deletion polymorphism of alpha - adrenoceptor gene in essential hypertension with or without type 2 diabetes mellitus in Malaysian subjects. Int J Biol Sci 2008; 4 (6): 362-7.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Dionne I.J, Garant M.J, Nolan A.A et al. Association between obesity and a polymorphism in the beta(1)-adrenoceptor gene (Gly389Arg ADRB1) in Caucasian women. Int J Obes Relat Metab Dis 2002; 26 (5): 633-9.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Linné Y, Dahlman I, Hoffstedt J. Beta1-Adrenoceptor gene polymorphism predicts long - term changes in body weight. Int J Obes (Lond) 2005; 29 (5): 458-62.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Воевода М.И., Максимов В.Н., Куликов И.В. Внезапная сердечная смерть и полиморфизм генов - кандидатов сердечно - сосудистых заболеваний. СМЭ Новосибирск, 2006; с. 23-7.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Mottagui-Tabar S, Hoffstedt J, Brookes A.J et al. Association of ADRB1 and UCP3 gene polymorphisms with insulin sensitivity but not obesity. Horm Res 2008; 69 (1): 31-6.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Gjesing A.P, Andersen G, Albrechtsen A et al. Studies of associations between the Arg389Gly polymorphism of the beta1-adrenergic receptor gene (ADRB1) and hypertension and obesity in 7677 Danish white subjects. Diabet Med 2007; 24(4): 392-7.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Terra S.G, Mc Gorray S.P, Wu R et al. Association between beta - adrenergic receptor polymorphisms and their G-protein - coupled receptors with body mass index and obesity in women: a report from the NHLBI-sponsored WISE study. Int J Obes (Lond) 2005; 29 (7): 746-54.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Souza-Costa D.C, Belo V.A, Silva P.S et al. eNOS haplotype associated with hypertension in obese children and adolescents. Int J Obes (Lond) 2011; 35 (3): 387-92.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Hoffmann I.S, Tavares-Mordwinkin R, Castejon A.M et al. Endothelial nitric oxide synthase polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics. J Hum Hypertens 2005; 19 (3): 233-40.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Miranda J.A, Belo V.A, Souza-Costa D.C et al. eNOS polymorphism associated with metabolic syndrome in children and adolescents. Mol Cell Biochem 2013; 372 (1-2): 155-60.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Kucukhuseyin O, Kurnaz O, Akadam-Teker A.B et al. The association of MTHFR C677T gene variants and lipid profiles or body mass index in patients with diabetic and nondiabetic coronary heart disease. J Clin Lab Anal 2013; 27 (6): 427-34.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Yang B, Fan S, Zhi X et al. Associations of MTHFR C677T and MTRR A66G gene polymorphisms with metabolic syndrome: a case - control study in Northern China. Int J Mol Sci 2014; 15 (12): 21687-702.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Chen A.R, Zhang H.G, Wang Z.P et al. C-reactive protein, vitamin B12 and C677T polymorphism of N-5,10-methylenetetrahydrofolate reductase gene are related to insulin resistance and risk factors for metabolic syndrome in Chinese population. Clin Invest Med 2010; 33 (5): E290-297.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Fan S, Yang B, Zhi X et al. Interactions of Methylenetetrahydrofolate Reductase C677T Polymorphism with Environmental Factors on Hypertension Susceptibility. Int J Environ Res Public Health 2016; 13 (6). pii: E601.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Russo G.T, Di Benedetto A, Alessi E et al. Mild hyperhomocysteinemia and the common C677T polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes. J Endocrinol Invest 2006; 29 (3): 201-7.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Uehara S.K, Rosa G. Association of homocysteinemia with high concentrations of serum insulin and uric acid in Brazilian subjects with metabolic syndrome genotyped for C677T polymorphism in the methylenetetrahydrofolate reductase gene. Nutr Res 2008; 28 (11): 760-6.</mixed-citation></ref></ref-list></back></article>
